Hereditary neuropathies (HMSN) are among the most common genetic disea
ses in neurology. Various mutations in different genes are known which
lead to the most frequent hereditary neuropathies. These mutations co
ncern proteins of the myelin of the peripheral nervous system, as well
as a gap-junction protein expressed in peripheral nerves. The molecul
ar mechanisms leading from gene mutation to disease phenotypes are not
fully understood. Nowadays, we are able to use DNA analysis for sympt
omatic, presymptomatic, and prenatal screening. The latter is of quest
ionable value because of the variability in disease severity and outco
me. Deeper insights into the molecular pathophysiology will, however,
yield new therapeutic strategies in individual patients.